Exact Mass: 460.291

Exact Mass Matches: 460.291

Found 168 metabolites which its exact mass value is equals to given mass value 460.291, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

ST 27:4;O6

Hydrocortisone caproate; [2-(11,17-Dihydroxy-10,13-dimethyl-3-oxo-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl)-2-oxo-ethyl]hexanoate

C27H40O6 (460.2825)


Same as: D09796

   

Lucidenic acid N

4-{5,9-dihydroxy-2,6,6,11,15-pentamethyl-12,17-dioxotetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-1(10)-en-14-yl}pentanoic acid

C27H40O6 (460.2825)


Lucidenic acid N is found in mushrooms. Lucidenic acid N is a constituent of Ganoderma lucidum (reishi).

   

2,3-Secoporrigenin

2-{5,7,9,13-tetramethyl-16-oxo-5,17-dioxaspiro[oxane-2,6-pentacyclo[10.7.0.0²,⁹.0⁴,⁸.0¹⁴,¹⁸]nonadecane]-13-yl}acetic acid

C27H40O6 (460.2825)


(6beta,25S)-2,3-Secospirostan-3,6-olid-2-oic acid is found in onion-family vegetables. (6beta,25S)-2,3-Secospirostan-3,6-olid-2-oic acid is a constituent of Allium porrum (leek)

   

Menatetrenone Epoxide

1a-methyl-7a-(3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl)-1aH,2H,7H,7aH-naphtho[2,3-b]oxirene-2,7-dione

C31H40O3 (460.2977)


   

Petrosaspongiolide m

[3-(2-hydroxy-5-oxo-2H-furan-3-yl)-4b,7,7,10a-tetramethyl-1,3,4,4a,5,6,6a,8,9,10,10b,11,12,12a-tetradecahydronaphtho[2,1-f]isochromen-1-yl] acetate

C27H40O6 (460.2825)


   

DG(2:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0)

(2S)-1-(acetyloxy)-3-hydroxypropan-2-yl (5Z,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoate

C27H40O6 (460.2825)


DG(2:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/2:0/0:0)

(2S)-2-(acetyloxy)-3-hydroxypropyl (5Z,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoate

C27H40O6 (460.2825)


DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid

C27H40O6 (460.2825)


DG(2:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid

C27H40O6 (460.2825)


DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (4Z,8Z,10Z,13Z,16Z,19Z)-7-hydroxydocosa-4,8,10,13,16,19-hexaenoic acid

C27H40O6 (460.2825)


DG(2:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (4Z,8Z,10Z,13Z,16Z,19Z)-7-hydroxydocosa-4,8,10,13,16,19-hexaenoic acid

C27H40O6 (460.2825)


DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (4Z,10Z,13Z,16Z,19Z)-7-hydroxydocosa-4,8,10,13,16,19-hexaenoic acid

C27H40O6 (460.2825)


DG(2:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (4Z,10Z,13Z,16Z,19Z)-7-hydroxydocosa-4,8,10,13,16,19-hexaenoic acid

C27H40O6 (460.2825)


DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0)

(2S)-1-(acetyloxy)-3-hydroxypropan-2-yl (4Z,7Z,10Z,12E,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoate

C27H40O6 (460.2825)


DG(2:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (4Z,7Z,10Z,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoic acid

C27H40O6 (460.2825)


DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14))

(2R)-3-(acetyloxy)-2-hydroxypropyl (4Z,7Z,10Z,12E,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoate

C27H40O6 (460.2825)


DG(2:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/2:0)

(2S)-3-(acetyloxy)-2-hydroxypropyl (4Z,7Z,10Z,12E,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoate

C27H40O6 (460.2825)


DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoic acid

C27H40O6 (460.2825)


DG(2:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoic acid

C27H40O6 (460.2825)


DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoic acid

C27H40O6 (460.2825)


DG(2:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoic acid

C27H40O6 (460.2825)


DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (4Z,7Z,10Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoic acid

C27H40O6 (460.2825)


DG(2:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (4Z,7Z,10Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoic acid

C27H40O6 (460.2825)


DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (4Z,7Z,10Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoic acid

C27H40O6 (460.2825)


DG(2:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (4Z,7Z,10Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoic acid

C27H40O6 (460.2825)


DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

Lucidenic acid N

(4R)-4-[(3S,5R,7S,10S,13R,14R,17R)-3,7-dihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid

C27H40O6 (460.2825)


Lucidenic acid N is a tetracyclic triterpenoid that is 25,26,27-trinorlanost-8-en-24-oic acid substituted by hydroxy groups at positions 3 and 7 and oxo groups at positions 11 and 15 respectively (the 3beta,5alpha,7beta stereoisomer). Isolated from the fruiting bodies of Ganoderma lucidum, it exhibits cytotoxicity against tumour cells. It has a role as a metabolite, an EC 3.1.1.8 (cholinesterase) inhibitor and an antineoplastic agent. It is a tetracyclic triterpenoid, a cyclic terpene ketone, a dioxo monocarboxylic acid and a secondary alcohol. Lucidenic acid N is a natural product found in Ganoderma lucidum and Bos taurus with data available. A tetracyclic triterpenoid that is 25,26,27-trinorlanost-8-en-24-oic acid substituted by hydroxy groups at positions 3 and 7 and oxo groups at positions 11 and 15 respectively (the 3beta,5alpha,7beta stereoisomer). Isolated from the fruiting bodies of Ganoderma lucidum, it exhibits cytotoxicity against tumour cells. Constituent of Ganoderma lucidum (reishi). Lucidenic acid N is found in mushrooms.

   

Petrosaspongiolide M

Petrosaspongiolide M

C27H40O6 (460.2825)


   

Hyperielliptone HB

Hyperielliptone HB

C27H40O6 (460.2825)


   

NSC661429

NSC661429

C27H40O6 (460.2825)


   

Spongianolide A

Spongianolide A

C27H40O6 (460.2825)


   

Luffolide

Luffolide

C27H40O6 (460.2825)


   

Hyperielliptone HA

Hyperielliptone HA

C27H40O6 (460.2825)


   

Stypohydroperoxide

Stypohydroperoxide

C27H40O6 (460.2825)


   

12beta,20-Dihydroxy-16beta-Acetoxy-17-scalaren-19,20-olide

12beta,20-Dihydroxy-16beta-Acetoxy-17-scalaren-19,20-olide

C27H40O6 (460.2825)


   

C27H40O6

C27H40O6 (460.2825)


   

neovibsanin L

neovibsanin L

C27H40O6 (460.2825)


   

petrosaspongiolide A

petrosaspongiolide A

C27H40O6 (460.2825)


   

neoporrigenin C

neoporrigenin C

C27H40O6 (460.2825)


   

hyatelone A

hyatelone A

C27H40O6 (460.2825)


   

2-Propyl-8-hydroxymethyl-12,14-dimethyl-15-benzyl-1-oxa-7,14-diazacyclohexadecane-6,13,16-trione

2-Propyl-8-hydroxymethyl-12,14-dimethyl-15-benzyl-1-oxa-7,14-diazacyclohexadecane-6,13,16-trione

C26H40N2O5 (460.2937)


   

hyatolide A

hyatolide A

C27H40O6 (460.2825)


   

namogenin C|spirosta-5,25(27)-dien-1beta,3beta,14alpha,17alpha-tetrol

namogenin C|spirosta-5,25(27)-dien-1beta,3beta,14alpha,17alpha-tetrol

C27H40O6 (460.2825)


   

3alpha-(4-pent-2E-enoyloxy-pent-2E-enoyloxy)-9alpha-hydroxy-7beta,10alphaH-eremophil-11-ene-8-one|3alpha-<4-pent-2E-enoyloxy-pent-2E-enoyloxy>-9alpha-hydroxy-7beta,10alphaH-eremophil-11-ene-8-one

3alpha-(4-pent-2E-enoyloxy-pent-2E-enoyloxy)-9alpha-hydroxy-7beta,10alphaH-eremophil-11-ene-8-one|3alpha-<4-pent-2E-enoyloxy-pent-2E-enoyloxy>-9alpha-hydroxy-7beta,10alphaH-eremophil-11-ene-8-one

C27H40O6 (460.2825)


   

dracogenin

dracogenin

C27H40O6 (460.2825)


   

3alpha,9beta,13alpha-trihydroxy-11(12),15(17)-trinervitadiene propionate diacetate

3alpha,9beta,13alpha-trihydroxy-11(12),15(17)-trinervitadiene propionate diacetate

C27H40O6 (460.2825)


   

spirosta-5,25(27)-diene-1beta,2alpha,3beta,12beta-tetrol

spirosta-5,25(27)-diene-1beta,2alpha,3beta,12beta-tetrol

C27H40O6 (460.2825)


   

yojironin H

yojironin H

C27H40O6 (460.2825)


   

yojironin I

yojironin I

C27H40O6 (460.2825)


   

Hydrocortisone tebutate

Hydrocortisone tebutate

C27H40O6 (460.2825)


   

6-Angeloyl,7-Ac-6,7-Dihydroxy-3,13-clerodadien-15-oic acid

6-Angeloyl,7-Ac-6,7-Dihydroxy-3,13-clerodadien-15-oic acid

C27H40O6 (460.2825)


   

7beta-hydroxy-11-oxo-3,4-seco-25,26,27-trinorlanosta-4(28),8-dien-3,24-dioic acid|fornicatin B

7beta-hydroxy-11-oxo-3,4-seco-25,26,27-trinorlanosta-4(28),8-dien-3,24-dioic acid|fornicatin B

C27H40O6 (460.2825)


   

3alpha-(4-pent-2E-enoyloxy-pent-2E-enoyloxy)-9alpha-hydroxy-10alphaH-eremophil-7(11)-ene-8-one|3alpha-<4-pent-2E-enoyloxy-pent-2E-enoyloxy>-9alpha-hydroxy-10alphaH-eremophil-7(11)-ene-8-one

3alpha-(4-pent-2E-enoyloxy-pent-2E-enoyloxy)-9alpha-hydroxy-10alphaH-eremophil-7(11)-ene-8-one|3alpha-<4-pent-2E-enoyloxy-pent-2E-enoyloxy>-9alpha-hydroxy-10alphaH-eremophil-7(11)-ene-8-one

C27H40O6 (460.2825)


   

12-alpha-O-acetylhyrtiolide

12-alpha-O-acetylhyrtiolide

C27H40O6 (460.2825)


   

15,18-di-O-methylvibsanin H

15,18-di-O-methylvibsanin H

C27H40O6 (460.2825)


   

furanovibsanin G

furanovibsanin G

C27H40O6 (460.2825)


   

3β,7β,15β-Trihydroxy-11-oxo-lanosta-8-en-24→20 lactone

5-METHYL-5-((3S,5R,7S,10S,13R,14R,15R,17S)-3,7,15-TRIHYDROXY-4,4,10,13,14-PENTAMETHYL-11-OXO-2,3,4,5,6,7,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17-YL)DIHYDROFURAN-2(3H)-ONE

C27H40O6 (460.2825)


   

7,15-Dihydroxy-4,4,14-trimethyl-3,11-dioxochol-8-en-24-oic acid

(4R)-4-[(5R,10S,13R,14R,17R)-7,15-dihydroxy-4,4,10,13,14-pentamethyl-3,11-dioxo-2,5,6,7,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid

C27H40O6 (460.2825)


   

Lys Lys Ser Val

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2,6-diaminohexanamido]hexanamido]-3-hydroxypropanamido]-3-methylbutanoic acid

C20H40N6O6 (460.3009)


   

Lys Lys Val Ser

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2,6-diaminohexanamido]hexanamido]-3-methylbutanamido]-3-hydroxypropanoic acid

C20H40N6O6 (460.3009)


   

Lys Ser Lys Val

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxypropanamido]hexanamido]-3-methylbutanoic acid

C20H40N6O6 (460.3009)


   

Lys Ser Val Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxypropanamido]-3-methylbutanamido]hexanoic acid

C20H40N6O6 (460.3009)


   

Lys Val Lys Ser

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-methylbutanamido]hexanamido]-3-hydroxypropanoic acid

C20H40N6O6 (460.3009)


   

Lys Val Ser Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-methylbutanamido]-3-hydroxypropanamido]hexanoic acid

C20H40N6O6 (460.3009)


   

Ser Lys Lys Val

(2S)-2-[(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-amino-3-hydroxypropanamido]hexanamido]hexanamido]-3-methylbutanoic acid

C20H40N6O6 (460.3009)


   

Ser Lys Val Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-hydroxypropanamido]hexanamido]-3-methylbutanamido]hexanoic acid

C20H40N6O6 (460.3009)


   

Ser Val Lys Lys

(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-methylbutanamido]hexanamido]hexanoic acid

C20H40N6O6 (460.3009)


   

Val Lys Lys Ser

(2S)-2-[(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-amino-3-methylbutanamido]hexanamido]hexanamido]-3-hydroxypropanoic acid

C20H40N6O6 (460.3009)


   

Val Lys Ser Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-methylbutanamido]hexanamido]-3-hydroxypropanamido]hexanoic acid

C20H40N6O6 (460.3009)


   

Val Ser Lys Lys

(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-hydroxypropanamido]hexanamido]hexanoic acid

C20H40N6O6 (460.3009)


   

2,3-Secoporrigenin

2-{5,7,9,13-tetramethyl-16-oxo-5,17-dioxaspiro[oxane-2,6-pentacyclo[10.7.0.0^{2,9}.0^{4,8}.0^{14,18}]nonadecane]-13-yl}acetic acid

C27H40O6 (460.2825)


   

Omega-hydroxymenaquinone-4

2-[(2E,6E,10E,14E)-16-hydroxy-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl]-3-methyl-1,4-naphthoquinone

C31H40O3 (460.2977)


A prenylnaphthoquinone obtained by hydroxylation of one of the terminal methyl groups of menaquinone-4.

   

6b-Hydroxymethandienone

17-Methyl-6,17-bis[(trimethylsilyl)oxy]androsta-1,4-dien-3-one

C26H44O3Si2 (460.2829)


6b-Hydroxymethandienone is a metabolite of the androgen metandienone metabolite, excreted in the urine. Metandienone has been used in horse doping and by weightlifters and body builders. It is of note to consider that the use of anabolic steroids for an extended period of time reduces the excretion of endogenous metabolites, making the detection of doping a little more difficult. (PMID: 16040239, 757586, 9001954, 2745643, 12375280, 8539789, 1400752, 757586, 17610244) [HMDB]

   

Desethanol Dipyridamole

Desethanol Dipyridamole

C22H36N8O3 (460.291)


   

Azacosterol hydrochloride

Azacosterol hydrochloride

C25H46Cl2N2O (460.2987)


   

3-(Aminomethyl)-5-(4-pyridyl)pyrazole

3-(Aminomethyl)-5-(4-pyridyl)pyrazole

C20H40N6O6 (460.3009)


   

Acetyl simvastatin

Acetyl simvastatin

C27H40O6 (460.2825)


   

1,1-[Oxybis(methylene-4,1-phenyleneoxy)]bis[3-(isopropylamino)-2-propanol]

1,1-[Oxybis(methylene-4,1-phenyleneoxy)]bis[3-(isopropylamino)-2-propanol]

C26H40N2O5 (460.2937)


   

Menatetrenone Epoxide

Menatetrenone Epoxide

C31H40O3 (460.2977)


   

Hydrocortisone caproate

Hydrocortisone caproate

C27H40O6 (460.2825)


   

DG(2:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0)

DG(2:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0)

C27H40O6 (460.2825)


   

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/2:0/0:0)

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/2:0/0:0)

C27H40O6 (460.2825)


   

DG(2:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4))

DG(2:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4))

C27H40O6 (460.2825)


   

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/2:0)

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/2:0)

C27H40O6 (460.2825)


   

DG(2:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0)

DG(2:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0)

C27H40O6 (460.2825)


   

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/2:0/0:0)

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/2:0/0:0)

C27H40O6 (460.2825)


   

DG(2:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7))

DG(2:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7))

C27H40O6 (460.2825)


   

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/2:0)

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/2:0)

C27H40O6 (460.2825)


   

DG(2:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0)

DG(2:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0)

C27H40O6 (460.2825)


   

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/2:0/0:0)

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/2:0/0:0)

C27H40O6 (460.2825)


   

DG(2:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14))

DG(2:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14))

C27H40O6 (460.2825)


   

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/2:0)

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/2:0)

C27H40O6 (460.2825)


   

DG(2:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0)

DG(2:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0)

C27H40O6 (460.2825)


   

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/2:0/0:0)

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/2:0/0:0)

C27H40O6 (460.2825)


   

DG(2:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17))

DG(2:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17))

C27H40O6 (460.2825)


   

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/2:0)

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/2:0)

C27H40O6 (460.2825)


   

DG(2:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0)

DG(2:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0)

C27H40O6 (460.2825)


   

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/2:0/0:0)

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/2:0/0:0)

C27H40O6 (460.2825)


   

DG(2:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17))

DG(2:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17))

C27H40O6 (460.2825)


   

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/2:0)

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/2:0)

C27H40O6 (460.2825)


   

2,3-epoxymenatetrenone

2,3-epoxymenatetrenone

C31H40O3 (460.2977)


A member of the class of tetralins obtained by formal epoxidation across the 2,3-double bond of menatetrenone.

   

TG(24:5)

TG(4:0_10:1_10:4)

C27H40O6 (460.2825)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

NA-Orn 21:5

NA-Orn 21:5

C26H40N2O5 (460.2937)


   

TG 24:5

TG 24:5

C27H40O6 (460.2825)


   

ST 21:3;O;Hex

ST 21:3;O;Hex

C27H40O6 (460.2825)


   

(1r,2r,4r,5s,8r,13s,14s,17s,18r,20r)-5,9,9,13-tetramethyl-22-oxo-19,21,24-trioxahexacyclo[16.5.1.0¹,²⁰.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-2-yl acetate

(1r,2r,4r,5s,8r,13s,14s,17s,18r,20r)-5,9,9,13-tetramethyl-22-oxo-19,21,24-trioxahexacyclo[16.5.1.0¹,²⁰.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-2-yl acetate

C27H40O6 (460.2825)


   

(3s,4ar,6ar,8s,10r,10ar,10bs)-8-(acetyloxy)-3-ethenyl-3,4a,7,7,10a-pentamethyl-5-oxo-octahydronaphtho[2,1-b]pyran-10-yl (2z)-2-methylbut-2-enoate

(3s,4ar,6ar,8s,10r,10ar,10bs)-8-(acetyloxy)-3-ethenyl-3,4a,7,7,10a-pentamethyl-5-oxo-octahydronaphtho[2,1-b]pyran-10-yl (2z)-2-methylbut-2-enoate

C27H40O6 (460.2825)


   

2-[2-(4-methoxy-4-methylpent-2-en-1-yl)-5-(methoxymethyl)-2-methyl-6-oxo-7-(2-oxopropyl)cyclohept-4-en-1-yl]ethenyl 3-methylbut-2-enoate

2-[2-(4-methoxy-4-methylpent-2-en-1-yl)-5-(methoxymethyl)-2-methyl-6-oxo-7-(2-oxopropyl)cyclohept-4-en-1-yl]ethenyl 3-methylbut-2-enoate

C27H40O6 (460.2825)


   

(1e)-2-[(4r,5s,7s,8s)-8-(hydroxymethyl)-7,8-dimethoxy-2,5-dimethyl-5-(4-methylpent-3-en-1-yl)-4h,6h,7h-cyclohepta[b]furan-4-yl]ethenyl 3-methylbut-2-enoate

(1e)-2-[(4r,5s,7s,8s)-8-(hydroxymethyl)-7,8-dimethoxy-2,5-dimethyl-5-(4-methylpent-3-en-1-yl)-4h,6h,7h-cyclohepta[b]furan-4-yl]ethenyl 3-methylbut-2-enoate

C27H40O6 (460.2825)


   

(1'r,2r,2's,4's,5s,7's,8'r,9's,12's,13'r,16'r,18's,19'r)-16',19'-dihydroxy-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-10',15'-dione

(1'r,2r,2's,4's,5s,7's,8'r,9's,12's,13'r,16'r,18's,19'r)-16',19'-dihydroxy-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-10',15'-dione

C27H40O6 (460.2825)


   

(2s,3as,5s)-3a-(3,7-dimethylocta-2,6-dien-1-yl)-5-hydroxy-2-(2-hydroxypropan-2-yl)-5-methyl-7-[(2r)-2-methylbutanoyl]-2,3-dihydro-1-benzofuran-4,6-dione

(2s,3as,5s)-3a-(3,7-dimethylocta-2,6-dien-1-yl)-5-hydroxy-2-(2-hydroxypropan-2-yl)-5-methyl-7-[(2r)-2-methylbutanoyl]-2,3-dihydro-1-benzofuran-4,6-dione

C27H40O6 (460.2825)


   

5,9,9,13-tetramethyl-22-oxo-19,21,24-trioxahexacyclo[16.5.1.0¹,²⁰.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-2-yl acetate

5,9,9,13-tetramethyl-22-oxo-19,21,24-trioxahexacyclo[16.5.1.0¹,²⁰.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-2-yl acetate

C27H40O6 (460.2825)


   

3-(2-hydroxy-5-oxo-2h-furan-3-yl)-4b,7,7,10a-tetramethyl-tetradecahydrophenanthro[2,1-c]pyran-1-yl acetate

3-(2-hydroxy-5-oxo-2h-furan-3-yl)-4b,7,7,10a-tetramethyl-tetradecahydrophenanthro[2,1-c]pyran-1-yl acetate

C27H40O6 (460.2825)


   

(1z)-2-[(1s,3s,5s,11s,12r)-3-methoxy-11-[(2e)-4-methoxy-4-methylpent-2-en-1-yl]-3,11-dimethyl-2,6-dioxatricyclo[6.4.0.0¹,⁵]dodec-8-en-12-yl]ethenyl 3-methylbut-2-enoate

(1z)-2-[(1s,3s,5s,11s,12r)-3-methoxy-11-[(2e)-4-methoxy-4-methylpent-2-en-1-yl]-3,11-dimethyl-2,6-dioxatricyclo[6.4.0.0¹,⁵]dodec-8-en-12-yl]ethenyl 3-methylbut-2-enoate

C27H40O6 (460.2825)


   

16',19'-dihydroxy-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-10',15'-dione

16',19'-dihydroxy-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-10',15'-dione

C27H40O6 (460.2825)


   

4-[6-(2-carboxyethyl)-9-hydroxy-3a,6,9b-trimethyl-5-oxo-7-(prop-1-en-2-yl)-1h,2h,3h,4h,7h,8h,9h-cyclopenta[a]naphthalen-3-yl]pentanoic acid

4-[6-(2-carboxyethyl)-9-hydroxy-3a,6,9b-trimethyl-5-oxo-7-(prop-1-en-2-yl)-1h,2h,3h,4h,7h,8h,9h-cyclopenta[a]naphthalen-3-yl]pentanoic acid

C27H40O6 (460.2825)


   

2-[3-methoxy-11-(4-methoxy-4-methylpent-2-en-1-yl)-3,11-dimethyl-2,6-dioxatricyclo[6.4.0.0¹,⁵]dodec-8-en-12-yl]ethenyl 3-methylbut-2-enoate

2-[3-methoxy-11-(4-methoxy-4-methylpent-2-en-1-yl)-3,11-dimethyl-2,6-dioxatricyclo[6.4.0.0¹,⁵]dodec-8-en-12-yl]ethenyl 3-methylbut-2-enoate

C27H40O6 (460.2825)


   

(3s,4as,6s)-4a-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-3,6-dihydroxy-2,2,6-trimethyl-8-[(2r)-2-methylbutanoyl]-3,4-dihydro-1-benzopyran-5,7-dione

(3s,4as,6s)-4a-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-3,6-dihydroxy-2,2,6-trimethyl-8-[(2r)-2-methylbutanoyl]-3,4-dihydro-1-benzopyran-5,7-dione

C27H40O6 (460.2825)


   

(4r)-4-[(1r,3ar,4s,5as,7s,9as,11ar)-4,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-3,10-dioxo-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]pentanoic acid

(4r)-4-[(1r,3ar,4s,5as,7s,9as,11ar)-4,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-3,10-dioxo-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]pentanoic acid

C27H40O6 (460.2825)


   

(1e)-2-[(1s,3r,5s,11s,12r)-3-methoxy-11-[(2e)-4-methoxy-4-methylpent-2-en-1-yl]-3,11-dimethyl-2,6-dioxatricyclo[6.4.0.0¹,⁵]dodec-8-en-12-yl]ethenyl 3-methylbut-2-enoate

(1e)-2-[(1s,3r,5s,11s,12r)-3-methoxy-11-[(2e)-4-methoxy-4-methylpent-2-en-1-yl]-3,11-dimethyl-2,6-dioxatricyclo[6.4.0.0¹,⁵]dodec-8-en-12-yl]ethenyl 3-methylbut-2-enoate

C27H40O6 (460.2825)


   

(2s,3ar)-4-hydroxy-7-{[(1r,2s,5r)-2-hydroxy-2-methyl-5-(prop-1-en-2-yl)cyclopentyl]methyl}-2-(2-hydroxypropan-2-yl)-3a-methyl-5-[(2r)-2-methylbutanoyl]-2,3-dihydro-1-benzofuran-6-one

(2s,3ar)-4-hydroxy-7-{[(1r,2s,5r)-2-hydroxy-2-methyl-5-(prop-1-en-2-yl)cyclopentyl]methyl}-2-(2-hydroxypropan-2-yl)-3a-methyl-5-[(2r)-2-methylbutanoyl]-2,3-dihydro-1-benzofuran-6-one

C27H40O6 (460.2825)


   

8-(acetyloxy)-3-ethenyl-3,4a,7,7,10a-pentamethyl-5-oxo-octahydronaphtho[2,1-b]pyran-10-yl 3-methylbut-2-enoate

8-(acetyloxy)-3-ethenyl-3,4a,7,7,10a-pentamethyl-5-oxo-octahydronaphtho[2,1-b]pyran-10-yl 3-methylbut-2-enoate

C27H40O6 (460.2825)


   

(2r,3as)-4-hydroxy-7-{[(1s,2r,5s)-2-hydroxy-2-methyl-5-(prop-1-en-2-yl)cyclopentyl]methyl}-2-(2-hydroxypropan-2-yl)-3a-methyl-5-[(2s)-2-methylbutanoyl]-2,3-dihydro-1-benzofuran-6-one

(2r,3as)-4-hydroxy-7-{[(1s,2r,5s)-2-hydroxy-2-methyl-5-(prop-1-en-2-yl)cyclopentyl]methyl}-2-(2-hydroxypropan-2-yl)-3a-methyl-5-[(2s)-2-methylbutanoyl]-2,3-dihydro-1-benzofuran-6-one

C27H40O6 (460.2825)


   

[2-(2-hydroxy-5-oxo-2h-furan-3-yl)-3b,6,6,9a-tetramethyl-dodecahydrophenanthro[2,1-b]furan-11a-yl]methyl acetate

[2-(2-hydroxy-5-oxo-2h-furan-3-yl)-3b,6,6,9a-tetramethyl-dodecahydrophenanthro[2,1-b]furan-11a-yl]methyl acetate

C27H40O6 (460.2825)


   

3',4,7'-trihydroxy-3',5,7'-trimethyl-5-(3-methylbut-2-en-1-yl)-3-(2-methylbutanoyl)-1',2',3'a,4',6',7'a-hexahydrospiro[cyclohexane-1,5'-inden]-3-ene-2,6-dione

3',4,7'-trihydroxy-3',5,7'-trimethyl-5-(3-methylbut-2-en-1-yl)-3-(2-methylbutanoyl)-1',2',3'a,4',6',7'a-hexahydrospiro[cyclohexane-1,5'-inden]-3-ene-2,6-dione

C27H40O6 (460.2825)


   

4-hydroxy-7-{[2-hydroxy-2-methyl-5-(prop-1-en-2-yl)cyclopentyl]methyl}-2-(2-hydroxypropan-2-yl)-3a-methyl-5-(2-methylbutanoyl)-2,3-dihydro-1-benzofuran-6-one

4-hydroxy-7-{[2-hydroxy-2-methyl-5-(prop-1-en-2-yl)cyclopentyl]methyl}-2-(2-hydroxypropan-2-yl)-3a-methyl-5-(2-methylbutanoyl)-2,3-dihydro-1-benzofuran-6-one

C27H40O6 (460.2825)


   

(1e)-2-[(1s,2s,7s)-2-[(2e)-4-methoxy-4-methylpent-2-en-1-yl]-5-(methoxymethyl)-2-methyl-6-oxo-7-(2-oxopropyl)cyclohept-4-en-1-yl]ethenyl 3-methylbut-2-enoate

(1e)-2-[(1s,2s,7s)-2-[(2e)-4-methoxy-4-methylpent-2-en-1-yl]-5-(methoxymethyl)-2-methyl-6-oxo-7-(2-oxopropyl)cyclohept-4-en-1-yl]ethenyl 3-methylbut-2-enoate

C27H40O6 (460.2825)


   

5,7',9',13'-tetramethyl-16'-oxo-5',17'-dioxaspiro[oxane-2,6'-pentacyclo[10.7.0.0²,⁹.0⁴,⁸.0¹⁴,¹⁸]nonadecan]-13'-ylacetic acid

5,7',9',13'-tetramethyl-16'-oxo-5',17'-dioxaspiro[oxane-2,6'-pentacyclo[10.7.0.0²,⁹.0⁴,⁸.0¹⁴,¹⁸]nonadecan]-13'-ylacetic acid

C27H40O6 (460.2825)


   

7',9',13'-trimethyl-5-methylidene-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-ene-2',8',14',16'-tetrol

7',9',13'-trimethyl-5-methylidene-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-ene-2',8',14',16'-tetrol

C27H40O6 (460.2825)


   

(1e)-2-[(1s,3s,5s,11s,12r)-3-methoxy-11-[(2e)-4-methoxy-4-methylpent-2-en-1-yl]-3,11-dimethyl-2,6-dioxatricyclo[6.4.0.0¹,⁵]dodec-8-en-12-yl]ethenyl 3-methylbut-2-enoate

(1e)-2-[(1s,3s,5s,11s,12r)-3-methoxy-11-[(2e)-4-methoxy-4-methylpent-2-en-1-yl]-3,11-dimethyl-2,6-dioxatricyclo[6.4.0.0¹,⁵]dodec-8-en-12-yl]ethenyl 3-methylbut-2-enoate

C27H40O6 (460.2825)


   

(3s,4as,6s)-4a-(3,7-dimethylocta-2,6-dien-1-yl)-3,6-dihydroxy-2,2,6-trimethyl-8-[(2r)-2-methylbutanoyl]-3,4-dihydro-1-benzopyran-5,7-dione

(3s,4as,6s)-4a-(3,7-dimethylocta-2,6-dien-1-yl)-3,6-dihydroxy-2,2,6-trimethyl-8-[(2r)-2-methylbutanoyl]-3,4-dihydro-1-benzopyran-5,7-dione

C27H40O6 (460.2825)


   

(1r)-2-[(1r,2s,4as,4bs,8as,10as)-2-formyl-4b,8,8,10a-tetramethyl-decahydro-1h-phenanthren-1-yl]-1-(2-hydroxy-5-oxo-2h-furan-3-yl)ethyl acetate

(1r)-2-[(1r,2s,4as,4bs,8as,10as)-2-formyl-4b,8,8,10a-tetramethyl-decahydro-1h-phenanthren-1-yl]-1-(2-hydroxy-5-oxo-2h-furan-3-yl)ethyl acetate

C27H40O6 (460.2825)


   

(1'r,2r,2's,4's,5s,7's,8'r,9's,12's,13'r,16'r,19'r)-16',19'-dihydroxy-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-10',15'-dione

(1'r,2r,2's,4's,5s,7's,8'r,9's,12's,13'r,16'r,19'r)-16',19'-dihydroxy-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-10',15'-dione

C27H40O6 (460.2825)


   

(1s,3r,4ar,4bs,6as,10as,10bs,12as)-3-[(2r)-2-hydroxy-5-oxo-2h-furan-3-yl]-4b,7,7,10a-tetramethyl-tetradecahydrophenanthro[2,1-c]pyran-1-yl acetate

(1s,3r,4ar,4bs,6as,10as,10bs,12as)-3-[(2r)-2-hydroxy-5-oxo-2h-furan-3-yl]-4b,7,7,10a-tetramethyl-tetradecahydrophenanthro[2,1-c]pyran-1-yl acetate

C27H40O6 (460.2825)


   

methyl 6'-(3-methoxy-3-oxopropyl)-2',3a,4,6',7-pentamethyl-6-oxo-5'-(prop-1-en-2-yl)-4,5-dihydro-3h-spiro[1-benzofuran-2,1'-cyclohexane]-5-carboxylate

methyl 6'-(3-methoxy-3-oxopropyl)-2',3a,4,6',7-pentamethyl-6-oxo-5'-(prop-1-en-2-yl)-4,5-dihydro-3h-spiro[1-benzofuran-2,1'-cyclohexane]-5-carboxylate

C27H40O6 (460.2825)


   

(1r,3'r,3'as,5r,7's,7'as)-2,3',7'-trihydroxy-3',5,7'-trimethyl-5-(3-methylbut-2-en-1-yl)-3-[(2s)-2-methylbutanoyl]-1',2',3'a,4',6',7'a-hexahydrospiro[cyclohexane-1,5'-inden]-2-ene-4,6-dione

(1r,3'r,3'as,5r,7's,7'as)-2,3',7'-trihydroxy-3',5,7'-trimethyl-5-(3-methylbut-2-en-1-yl)-3-[(2s)-2-methylbutanoyl]-1',2',3'a,4',6',7'a-hexahydrospiro[cyclohexane-1,5'-inden]-2-ene-4,6-dione

C27H40O6 (460.2825)


   

(1'r,2r,2'r,4's,7's,8's,9's,12's,13'r,14'r,16'r)-7',9',13'-trimethyl-5-methylidene-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-ene-2',8',14',16'-tetrol

(1'r,2r,2'r,4's,7's,8's,9's,12's,13'r,14'r,16'r)-7',9',13'-trimethyl-5-methylidene-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-ene-2',8',14',16'-tetrol

C27H40O6 (460.2825)


   

(1'r,2r,2's,4's,5s,7's,8'r,9's,12's,13'r,14's,18'r)-5,7',9',13'-tetramethyl-16'-oxo-5',17'-dioxaspiro[oxane-2,6'-pentacyclo[10.7.0.0²,⁹.0⁴,⁸.0¹⁴,¹⁸]nonadecan]-13'-ylacetic acid

(1'r,2r,2's,4's,5s,7's,8'r,9's,12's,13'r,14's,18'r)-5,7',9',13'-tetramethyl-16'-oxo-5',17'-dioxaspiro[oxane-2,6'-pentacyclo[10.7.0.0²,⁹.0⁴,⁸.0¹⁴,¹⁸]nonadecan]-13'-ylacetic acid

C27H40O6 (460.2825)


   

2-[8-(hydroxymethyl)-7,8-dimethoxy-2,5-dimethyl-5-(4-methylpent-3-en-1-yl)-4h,6h,7h-cyclohepta[b]furan-4-yl]ethenyl 3-methylbut-2-enoate

2-[8-(hydroxymethyl)-7,8-dimethoxy-2,5-dimethyl-5-(4-methylpent-3-en-1-yl)-4h,6h,7h-cyclohepta[b]furan-4-yl]ethenyl 3-methylbut-2-enoate

C27H40O6 (460.2825)


   

(1r)-2-[(1r,2s,4as,4bs,8as,10as)-2-formyl-4b,8,8,10a-tetramethyl-decahydro-1h-phenanthren-1-yl]-1-[(2r)-2-hydroxy-5-oxo-2h-furan-3-yl]ethyl acetate

(1r)-2-[(1r,2s,4as,4bs,8as,10as)-2-formyl-4b,8,8,10a-tetramethyl-decahydro-1h-phenanthren-1-yl]-1-[(2r)-2-hydroxy-5-oxo-2h-furan-3-yl]ethyl acetate

C27H40O6 (460.2825)


   

4-{4,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-3,10-dioxo-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}pentanoic acid

4-{4,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-3,10-dioxo-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}pentanoic acid

C27H40O6 (460.2825)


   

(3s,10r)-3-benzyl-12-hydroxy-10-(hydroxymethyl)-4,6-dimethyl-16-propyl-1-oxa-4,11-diazacyclohexadec-11-ene-2,5-dione

(3s,10r)-3-benzyl-12-hydroxy-10-(hydroxymethyl)-4,6-dimethyl-16-propyl-1-oxa-4,11-diazacyclohexadec-11-ene-2,5-dione

C26H40N2O5 (460.2937)


   

1,4-dihydroxy-5b,8,8,11a,13a-pentamethyl-3-oxo-1h,4h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h-chryseno[1,2-c]furan-13-yl acetate

1,4-dihydroxy-5b,8,8,11a,13a-pentamethyl-3-oxo-1h,4h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h-chryseno[1,2-c]furan-13-yl acetate

C27H40O6 (460.2825)


   

(1s,2r,4r,5s,8r,13s,14s,17s,18s,20s)-5,9,9,13-tetramethyl-22-oxo-19,21,24-trioxahexacyclo[16.5.1.0¹,²⁰.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-2-yl acetate

(1s,2r,4r,5s,8r,13s,14s,17s,18s,20s)-5,9,9,13-tetramethyl-22-oxo-19,21,24-trioxahexacyclo[16.5.1.0¹,²⁰.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-2-yl acetate

C27H40O6 (460.2825)


   

(1'r,2r,2's,4's,5r,7's,8'r,9's,12's,13'r,16'r,18's,19'r)-16',19'-dihydroxy-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-10',15'-dione

(1'r,2r,2's,4's,5r,7's,8'r,9's,12's,13'r,16'r,18's,19'r)-16',19'-dihydroxy-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-10',15'-dione

C27H40O6 (460.2825)


   

(1r,3r,4ar,4bs,10as,12as)-3-(2-hydroxy-5-oxo-2h-furan-3-yl)-4b,7,7,10a-tetramethyl-tetradecahydrophenanthro[2,1-c]pyran-1-yl acetate

(1r,3r,4ar,4bs,10as,12as)-3-(2-hydroxy-5-oxo-2h-furan-3-yl)-4b,7,7,10a-tetramethyl-tetradecahydrophenanthro[2,1-c]pyran-1-yl acetate

C27H40O6 (460.2825)


   

(1r,3's,3'ar,5s,7's,7'ar)-3',4,7'-trihydroxy-3',5,7'-trimethyl-5-(3-methylbut-2-en-1-yl)-3-[(2r)-2-methylbutanoyl]-1',2',3'a,4',6',7'a-hexahydrospiro[cyclohexane-1,5'-inden]-3-ene-2,6-dione

(1r,3's,3'ar,5s,7's,7'ar)-3',4,7'-trihydroxy-3',5,7'-trimethyl-5-(3-methylbut-2-en-1-yl)-3-[(2r)-2-methylbutanoyl]-1',2',3'a,4',6',7'a-hexahydrospiro[cyclohexane-1,5'-inden]-3-ene-2,6-dione

C27H40O6 (460.2825)


   

(2s,3as,5s)-3a-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-5-hydroxy-2-(2-hydroxypropan-2-yl)-5-methyl-7-[(2r)-2-methylbutanoyl]-2,3-dihydro-1-benzofuran-4,6-dione

(2s,3as,5s)-3a-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-5-hydroxy-2-(2-hydroxypropan-2-yl)-5-methyl-7-[(2r)-2-methylbutanoyl]-2,3-dihydro-1-benzofuran-4,6-dione

C27H40O6 (460.2825)


   

5-hydroxy-1,8a-dimethyl-6-oxo-7-(prop-1-en-2-yl)-octahydronaphthalen-2-yl 4-(hex-2-enoyloxy)hex-2-enoate

5-hydroxy-1,8a-dimethyl-6-oxo-7-(prop-1-en-2-yl)-octahydronaphthalen-2-yl 4-(hex-2-enoyloxy)hex-2-enoate

C27H40O6 (460.2825)


   

(1r,2r,4ar,5s,7s,8ar)-5-hydroxy-1,8a-dimethyl-6-oxo-7-(prop-1-en-2-yl)-octahydronaphthalen-2-yl (2z,4s)-4-[(2z)-hex-2-enoyloxy]hex-2-enoate

(1r,2r,4ar,5s,7s,8ar)-5-hydroxy-1,8a-dimethyl-6-oxo-7-(prop-1-en-2-yl)-octahydronaphthalen-2-yl (2z,4s)-4-[(2z)-hex-2-enoyloxy]hex-2-enoate

C27H40O6 (460.2825)


   

(4r)-4-[(3r,3ar,6s,7s,9s,9br)-6-(2-carboxyethyl)-9-hydroxy-3a,6,9b-trimethyl-5-oxo-7-(prop-1-en-2-yl)-1h,2h,3h,4h,7h,8h,9h-cyclopenta[a]naphthalen-3-yl]pentanoic acid

(4r)-4-[(3r,3ar,6s,7s,9s,9br)-6-(2-carboxyethyl)-9-hydroxy-3a,6,9b-trimethyl-5-oxo-7-(prop-1-en-2-yl)-1h,2h,3h,4h,7h,8h,9h-cyclopenta[a]naphthalen-3-yl]pentanoic acid

C27H40O6 (460.2825)


   

(1r,3'r,3'as,5r,7'r,7'as)-3',4,7'-trihydroxy-3',5,7'-trimethyl-5-(3-methylbut-2-en-1-yl)-3-[(2s)-2-methylbutanoyl]-1',2',3'a,4',6',7'a-hexahydrospiro[cyclohexane-1,5'-inden]-3-ene-2,6-dione

(1r,3'r,3'as,5r,7'r,7'as)-3',4,7'-trihydroxy-3',5,7'-trimethyl-5-(3-methylbut-2-en-1-yl)-3-[(2s)-2-methylbutanoyl]-1',2',3'a,4',6',7'a-hexahydrospiro[cyclohexane-1,5'-inden]-3-ene-2,6-dione

C27H40O6 (460.2825)


   

5-hydroxy-1,8a-dimethyl-6-oxo-7-(propan-2-ylidene)-hexahydro-1h-naphthalen-2-yl 4-(hex-2-enoyloxy)hex-2-enoate

5-hydroxy-1,8a-dimethyl-6-oxo-7-(propan-2-ylidene)-hexahydro-1h-naphthalen-2-yl 4-(hex-2-enoyloxy)hex-2-enoate

C27H40O6 (460.2825)


   

(1r,3'r,3'as,5s,7'r,7'as)-2,3',7'-trihydroxy-3',5,7'-trimethyl-5-(3-methylbut-2-en-1-yl)-3-(2-methylbutanoyl)-1',2',3'a,4',6',7'a-hexahydrospiro[cyclohexane-1,5'-inden]-2-ene-4,6-dione

(1r,3'r,3'as,5s,7'r,7'as)-2,3',7'-trihydroxy-3',5,7'-trimethyl-5-(3-methylbut-2-en-1-yl)-3-(2-methylbutanoyl)-1',2',3'a,4',6',7'a-hexahydrospiro[cyclohexane-1,5'-inden]-2-ene-4,6-dione

C27H40O6 (460.2825)


   

(2s,2's,3ar,4'as,4'bs,7's,8'ar,10'as)-3a-hydroperoxy-5,7'-dihydroxy-2',4'b,7,8',8',10'a-hexamethyl-2',3',4',4'a,5',6',7',8'a,9',10'-decahydro-3h-spiro[1-benzofuran-2,1'-phenanthren]-4-one

(2s,2's,3ar,4'as,4'bs,7's,8'ar,10'as)-3a-hydroperoxy-5,7'-dihydroxy-2',4'b,7,8',8',10'a-hexamethyl-2',3',4',4'a,5',6',7',8'a,9',10'-decahydro-3h-spiro[1-benzofuran-2,1'-phenanthren]-4-one

C27H40O6 (460.2825)


   

(3s,4ar,6ar,8s,10r,10ar,10bs)-8-(acetyloxy)-3-ethenyl-3,4a,7,7,10a-pentamethyl-5-oxo-octahydronaphtho[2,1-b]pyran-10-yl 3-methylbut-2-enoate

(3s,4ar,6ar,8s,10r,10ar,10bs)-8-(acetyloxy)-3-ethenyl-3,4a,7,7,10a-pentamethyl-5-oxo-octahydronaphtho[2,1-b]pyran-10-yl 3-methylbut-2-enoate

C27H40O6 (460.2825)


   

(1s,2r,4r,5s,13s,17s,18s,20s)-5,9,9,13-tetramethyl-22-oxo-19,21,24-trioxahexacyclo[16.5.1.0¹,²⁰.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-2-yl acetate

(1s,2r,4r,5s,13s,17s,18s,20s)-5,9,9,13-tetramethyl-22-oxo-19,21,24-trioxahexacyclo[16.5.1.0¹,²⁰.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-2-yl acetate

C27H40O6 (460.2825)


   

(1s,3r,4ar,4bs,6as,10as,10bs,12as)-3-(2-hydroxy-5-oxo-2h-furan-3-yl)-4b,7,7,10a-tetramethyl-tetradecahydrophenanthro[2,1-c]pyran-1-yl acetate

(1s,3r,4ar,4bs,6as,10as,10bs,12as)-3-(2-hydroxy-5-oxo-2h-furan-3-yl)-4b,7,7,10a-tetramethyl-tetradecahydrophenanthro[2,1-c]pyran-1-yl acetate

C27H40O6 (460.2825)


   

8-(acetyloxy)-3-ethenyl-3,4a,7,7,10a-pentamethyl-5-oxo-octahydronaphtho[2,1-b]pyran-10-yl 2-methylbut-2-enoate

8-(acetyloxy)-3-ethenyl-3,4a,7,7,10a-pentamethyl-5-oxo-octahydronaphtho[2,1-b]pyran-10-yl 2-methylbut-2-enoate

C27H40O6 (460.2825)


   

(1r,3r,4ar,4bs,6as,10as,10bs,12as)-3-[(2s)-2-hydroxy-5-oxo-2h-furan-3-yl]-4b,7,7,10a-tetramethyl-tetradecahydrophenanthro[2,1-c]pyran-1-yl acetate

(1r,3r,4ar,4bs,6as,10as,10bs,12as)-3-[(2s)-2-hydroxy-5-oxo-2h-furan-3-yl]-4b,7,7,10a-tetramethyl-tetradecahydrophenanthro[2,1-c]pyran-1-yl acetate

C27H40O6 (460.2825)


   

(1r,3r,4ar,4bs,6as,10as,10bs,12as)-3-[(2r)-2-hydroxy-5-oxo-2h-furan-3-yl]-4b,7,7,10a-tetramethyl-tetradecahydrophenanthro[2,1-c]pyran-1-yl acetate

(1r,3r,4ar,4bs,6as,10as,10bs,12as)-3-[(2r)-2-hydroxy-5-oxo-2h-furan-3-yl]-4b,7,7,10a-tetramethyl-tetradecahydrophenanthro[2,1-c]pyran-1-yl acetate

C27H40O6 (460.2825)


   

(1'r,2r,2's,4's,5r,7's,8'r,9's,12's,13'r,14's,18'r)-5,7',9',13'-tetramethyl-16'-oxo-5',17'-dioxaspiro[oxane-2,6'-pentacyclo[10.7.0.0²,⁹.0⁴,⁸.0¹⁴,¹⁸]nonadecan]-13'-ylacetic acid

(1'r,2r,2's,4's,5r,7's,8'r,9's,12's,13'r,14's,18'r)-5,7',9',13'-tetramethyl-16'-oxo-5',17'-dioxaspiro[oxane-2,6'-pentacyclo[10.7.0.0²,⁹.0⁴,⁸.0¹⁴,¹⁸]nonadecan]-13'-ylacetic acid

C27H40O6 (460.2825)


   

(1r,4r,5as,5br,7as,11as,11br,13s,13as)-1,4-dihydroxy-5b,8,8,11a,13a-pentamethyl-3-oxo-1h,4h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h-chryseno[1,2-c]furan-13-yl acetate

(1r,4r,5as,5br,7as,11as,11br,13s,13as)-1,4-dihydroxy-5b,8,8,11a,13a-pentamethyl-3-oxo-1h,4h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h-chryseno[1,2-c]furan-13-yl acetate

C27H40O6 (460.2825)


   

{2-hydroxy-1-[2-(2-hydroxy-5-oxo-2h-furan-3-yl)ethenyl]-4b,8,8,10a-tetramethyl-decahydrophenanthren-2-yl}methyl acetate

{2-hydroxy-1-[2-(2-hydroxy-5-oxo-2h-furan-3-yl)ethenyl]-4b,8,8,10a-tetramethyl-decahydrophenanthren-2-yl}methyl acetate

C27H40O6 (460.2825)


   

methyl (2s,2's,3ar,4s,5s,5's,6's)-6'-(3-methoxy-3-oxopropyl)-2',3a,4,6',7-pentamethyl-6-oxo-5'-(prop-1-en-2-yl)-4,5-dihydro-3h-spiro[1-benzofuran-2,1'-cyclohexane]-5-carboxylate

methyl (2s,2's,3ar,4s,5s,5's,6's)-6'-(3-methoxy-3-oxopropyl)-2',3a,4,6',7-pentamethyl-6-oxo-5'-(prop-1-en-2-yl)-4,5-dihydro-3h-spiro[1-benzofuran-2,1'-cyclohexane]-5-carboxylate

C27H40O6 (460.2825)


   

(1s,3'r,3'as,5r,7'r,7'as)-3',4,7'-trihydroxy-3',5,7'-trimethyl-5-(3-methylbut-2-en-1-yl)-3-(2-methylbutanoyl)-1',2',3'a,4',6',7'a-hexahydrospiro[cyclohexane-1,5'-inden]-3-ene-2,6-dione

(1s,3'r,3'as,5r,7'r,7'as)-3',4,7'-trihydroxy-3',5,7'-trimethyl-5-(3-methylbut-2-en-1-yl)-3-(2-methylbutanoyl)-1',2',3'a,4',6',7'a-hexahydrospiro[cyclohexane-1,5'-inden]-3-ene-2,6-dione

C27H40O6 (460.2825)


   

8-[(4s,5r,6r,9s,10r,12r,14r)-4,5,6-trihydroxy-3,11,11,14-tetramethyl-15-oxotetracyclo[7.5.1.0¹,⁵.0¹⁰,¹²]pentadeca-2,7-dien-7-yl]octanoic acid

8-[(4s,5r,6r,9s,10r,12r,14r)-4,5,6-trihydroxy-3,11,11,14-tetramethyl-15-oxotetracyclo[7.5.1.0¹,⁵.0¹⁰,¹²]pentadeca-2,7-dien-7-yl]octanoic acid

C27H40O6 (460.2825)


   

(1r,2r,4ar,5s,8ar)-5-hydroxy-1,8a-dimethyl-6-oxo-7-(propan-2-ylidene)-hexahydro-1h-naphthalen-2-yl (2z,4s)-4-[(2z)-hex-2-enoyloxy]hex-2-enoate

(1r,2r,4ar,5s,8ar)-5-hydroxy-1,8a-dimethyl-6-oxo-7-(propan-2-ylidene)-hexahydro-1h-naphthalen-2-yl (2z,4s)-4-[(2z)-hex-2-enoyloxy]hex-2-enoate

C27H40O6 (460.2825)


   

(2r,3ar)-6-hydroxy-7-{[(1s,2r)-2-hydroxy-2-methyl-5-(prop-1-en-2-yl)cyclopentyl]methyl}-2-(2-hydroxypropan-2-yl)-3a-methyl-5-(2-methylbutanoyl)-2,3-dihydro-1-benzofuran-4-one

(2r,3ar)-6-hydroxy-7-{[(1s,2r)-2-hydroxy-2-methyl-5-(prop-1-en-2-yl)cyclopentyl]methyl}-2-(2-hydroxypropan-2-yl)-3a-methyl-5-(2-methylbutanoyl)-2,3-dihydro-1-benzofuran-4-one

C27H40O6 (460.2825)